Amp Volatility Score
Catalyst Info & Data Links
Potential Catalyst Events
From 2019 10K: "as well as our oral dual PAK4/NAMPT inhibitor, KPT-9274. ... We began clinical testing of KPT-9274 in patients with hematologic or solid tumors during 2016 and we plan to study its combination with an anti-PD1 monoclonal antibody in a phase 1 clinical study in the near future"
HC updated 5/22/20
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See What The Community Is Saying - Click To See Full Post